Join the most important conference in the Jewish world
Beduin doctor: Migraines common during Ramadan fast
By
August 9, 2010 09:40
Healthy Muslims who get migraines during Ramadan invited to participate in Jerusalem clinical trial.
SHOPPERS WALK past a pharmacy in the Muslim Quarter in Jerusalem’s Old City yesterday. If Ramadan fa

Arab pharmacy 311. (photo credit:Marc Israel Sellem/The Jerusalem Post)

Doctors at Jerusalem's Shaare Zedek Medical Center have invited healthy Muslims aged 18 to 65 who suffer from migraine headaches during the month-long dawn-to-dusk fast of Ramadan to participate in a clinical trial for prevention of the pain.

An estimated 90 million of the world’s 1.57 billion Muslims are likely to suffer from migraine headaches during Ramadan – which begins on Wednesday, at the height of summer heat. After Jewish researchers in Israel and the US and found that the COX-2 inhibitor etoricoxib (commercial name Arcoxia) reduces the rate of migraines during the 25-hour Jewish fast of Yom Kippur, a Shaare Zedek team headed by Dr. Michael J. Drescher and Dr. Zev Wimpfheimer are testing Muslims who want to volunteer for the clinical trial.



Be the first to know - Join our Facebook page.


Writing in the journal Headache, Drescher and colleagues noted that they had previously recommended a different Cox-2 inhibitor, Vioxx, but it was taken off the market because it caused a higher risk of cardiovascular complications in some people taking it for 18 months or longer. Thus they studied a “cousin” of Vioxx that is regarded as safer and is still prescribed.

Before Yom Kippur, they enrolled 211 Jewish patients, some of whom received the drug, with the rest getting a placebo. They found that those who received etoricoxib had a much easier fast compared to previous fasts. As the drug has a half-life of 22 hours and the team suggested it could be suitable for preventing or alleviating the headaches associated with short fasts.

The clinical trial for Muslims is double-blinded, with neither the doctors nor the participants knowing who is taking the etoricoxib half of the month and a harmless placebo the rest of the month. Anyone who wants to participate in the free trial should call (052) 337-4676 or go into the Web site www.ramadanheadache.com.

“It seems unlikely that short term (or single-dose) use of etoricoxib in the context of preventing fasting headache would pose” a risk to the cardiovascular system, Drescher said.

Meanwhile, Dr. Ibrahim Abu-Salameh, Israel’s only Beduin neurologist – who works at Soroka University Medical Center in Beersheba – headed a team that found migraine attacks are three times more common during the Muslim fast than in the rest of the year.

Working with colleagues Dr. Igal Plecht and Dr. Gal Ifergan of the Beersheba hospital, Abu-Salameh studied 32 Beduin who suffered from migraine attacks during the Ramadan fast last year and compared the statistics to an ordinary month without the fast as a control.

Migraines were much more common in women than men; three-quarters of the women complained of migraine while fasting, compared to a much lower figure among the men. The Soroka study was published recently in the Journal of Headache and Pain.


Because the Muslim calendar is a lunar one (with no leap years, as in the Jewish calendar), the month of Ramadan moves gradually backward through the seasons. When it occurs in the summer, the fasts are longer, due to the many hours of sunlight, and harder because of the hot weather.

Abu-Salameh said that he has gotten migraine headaches during Ramadan, and has treated Beduin who came to his clinic complaining about severe headaches. He noted that the medical literature has almost ignored the phenomenon until now.
Relevant to your professional network? Please share on Linkedin

Tags:
  • beduin
  • ramadan
  • Prev Article
    Hebrew University med. students to train in Clalit clinics
    Medical staff at a hospital
    West Nile fever kills elderly woman
    Next Article
    Share this article via
    from around the web
    Related Content
    [illustrative photo]
    September 24, 2011
    Diabetes may significantly increase risk of dementia

    By UNIVERSITY OF MICHIGAN HEALTH SYSTEM

    Top Stories
    Israel Weather
    • 4 - 18
      Beer Sheva
      7 - 18
      Tel Aviv - Yafo
    • 5 - 15
      Jerusalem
      8 - 17
      Haifa
    • 9 - 23
      Elat
      8 - 21
      Tiberias